dalteparin has been researched along with n-formylmethionine leucyl-phenylalanine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jankowska, R; Jutel, M; Krasnowska, M; Zak-Nejmark, T | 1 |
| Barbanti, M; Cerletti, C; de Gaetano, G; Donati, MB; Maugeri, N | 1 |
2 other study(ies) available for dalteparin and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
Heparin modulates migration of human peripheral blood mononuclear cells and neutrophils.
Topics: Adult; Anticoagulants; Cell Movement; Chemotactic Factors; Chemotaxis, Leukocyte; Heparin; Humans; Interleukin-8; Leukocytes, Mononuclear; N-Formylmethionine Leucyl-Phenylalanine; Nadroparin; Neutrophils | 1999 |
Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin.
Topics: Anti-Inflammatory Agents; Blood Platelets; Cell Adhesion; Fibrinolytic Agents; Flow Cytometry; Heparin; Heparin, Low-Molecular-Weight; Humans; L-Selectin; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; P-Selectin; Platelet Activation; Time Factors | 2005 |